Investing Ideas
/
U.S. High Growth Potential Companies

U.S. High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1498

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

1,498 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
AXSM Axsome Therapeutics	US$137.75	5.0%	74.5%	US$6.7b	US$166.12	PS17.4x	E58.7%	n/a	Pharmaceuticals & Biotech
ZK ZEEKR Intelligent Technology Holding	US$24.47	-7.1%	n/a	US$6.1b	US$36.15	PS0.6x	E71.6%	n/a	Automobiles
ZVRA Zevra Therapeutics	US$7.68	-4.8%	15.8%	US$409.9m	US$20.75	PS16.7x	E57.2%	n/a	Pharmaceuticals & Biotech
ONON On Holding	US$48.44	-6.9%	50.4%	US$15.5b	US$63.62	PE110.4x	E30.2%	n/a	Consumer Durables
ALNY Alnylam Pharmaceuticals	US$250.59	-2.3%	59.0%	US$32.4b	US$301.27	PS14.4x	E59.1%	n/a	Pharmaceuticals & Biotech
KINS Kingstone Companies	US$16.25	-9.3%	438.1%	US$200.7m	US$18.00	PE12.6x	E24.9%	0%	Insurance
ALKT Alkami Technology	US$31.14	-5.3%	21.5%	US$3.1b	US$45.10	PS9.9x	E102.7%	n/a	Software
ARES Ares Management	US$174.09	-6.5%	32.0%	US$55.1b	US$198.57	PE79.7x	E41.4%	2.6%	Diversified Financials
RCEL AVITA Medical	US$9.75	-7.8%	-43.0%	US$257.0m	US$16.29	PS4x	E55.3%	n/a	Pharmaceuticals & Biotech
TGTX TG Therapeutics	US$30.88	0.6%	131.8%	US$4.4b	US$40.33	PS16.7x	E45.2%	n/a	Pharmaceuticals & Biotech
TVTX Travere Therapeutics	US$21.98	-4.1%	176.8%	US$1.9b	US$32.73	PS8.2x	E67.3%	n/a	Pharmaceuticals & Biotech
NVDA NVIDIA	US$134.43	-3.2%	70.6%	US$3.3t	US$172.22	PE52.2x	E21.6%	0.03%	Semiconductors
LITE Lumentum Holdings	US$73.35	-5.6%	49.4%	US$5.1b	US$100.00	PS3.6x	E118.6%	n/a	Tech
OMF OneMain Holdings	US$54.17	-4.9%	16.6%	US$6.5b	US$61.92	PE12.7x	E27.8%	7.7%	Diversified Financials
LB LandBridge	US$65.21	-6.8%	n/a	US$5.6b	US$73.13	PE292.9x	E70.0%	0.6%	Real Estate Management and Development
ATAT Atour Lifestyle Holdings	US$31.26	1.5%	59.7%	US$4.3b	US$34.14	PE26.8x	E25.6%	1.4%	Consumer Services
NU Nu Holdings	US$10.82	-21.0%	5.9%	US$51.8b	US$14.99	PB6.8x	E27.6%	n/a	Banks
TBBB BBB Foods	US$28.03	0.04%	34.3%	US$3.1b	US$34.09	PE246.1x	E41.1%	n/a	Consumer Retailing
ATLC Atlanticus Holdings	US$57.27	-4.3%	73.5%	US$844.1m	US$65.00	PE10.4x	E27.7%	n/a	Diversified Financials
ALAB Astera Labs	US$85.72	-2.4%	n/a	US$13.9b	US$124.53	PS35.1x	E61.1%	n/a	Semiconductors
UPST Upstart Holdings	US$71.77	-12.9%	196.1%	US$6.7b	US$78.77	PS9.9x	E103.4%	n/a	Diversified Financials
ITCI Intra-Cellular Therapies	US$128.60	0.6%	83.3%	US$13.7b	US$132.73	PS20.1x	E50.0%	n/a	Pharmaceuticals & Biotech
GPOR Gulfport Energy	US$185.15	0.7%	31.7%	US$3.3b	US$213.00	PE14.9x	E36.2%	n/a	Energy
SMCI Super Micro Computer	US$56.07	17.0%	-34.8%	US$32.8b	US$47.88	PE27.2x	E27.6%	n/a	Tech

Page 1 of 63